HCRN-MCC20-443

A Single Arm Phase II Study with Safety Run-in of Peptide Receptor Radionuclide Therapy (PRRT) in Combination with Immunotherapy for Patients with Merkel Cell Cancer (iPRRT Study)

Status

Currently Enrolling

Cancer Type(s)

Trial Locations

All sites in which the trial HCRN-MCC20-443 being conducted in.